Displaying drugs 14776 - 14800 of 14815 in total
Darinaparsin
Investigational
Matched Iupac: … (2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-[(dimethylarsanyl)sulfanyl]ethyl]carbamoyl}butanoic …
SEphB4-HSA
SEphB4-HSA is under investigation in clinical trial NCT02495896 (Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors).
Investigational
Matched Description: … SEphB4-HSA is under investigation in clinical trial NCT02495896 (Recombinant EphB4-HSA Fusion Protein ... With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors). …
Nicotinamide riboside
Nicotinamide riboside is under investigation in clinical trial NCT03432871 (Nicotinamide Riboside and Mitochondrial Biogenesis).
Investigational
Matched Iupac: … 3-carbamoyl-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1lambda5-pyridin-1-ylium …
Matched Description: … Nicotinamide riboside is under investigation in clinical trial NCT03432871 (Nicotinamide Riboside and …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Matched Description: … Nicotinamide riboside is under investigation in clinical trial NCT03432871 (Nicotinamide Riboside and …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Teceleukin
Teceleukin is under investigation in clinical trial NCT03610490 (Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Osteosarcoma, or Pancreatic Ductal Adenocarcinoma).
Investigational
Matched Description: … Teceleukin is under investigation in clinical trial NCT03610490 (Autologous Tumor Infiltrating Lymphocytes ... MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Osteosarcoma, or Pancreatic …
Dilanubicel
Dilanubicel consists of ex vivo expanded hematopoietic stem and progenitor cells.
Investigational
Matched Description: … Dilanubicel consists of ex vivo expanded hematopoietic stem and progenitor cells. …
Janagliflozin
Janagliflozin is under investigation in clinical trial NCT03851432 (Janagliflozin Treat Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Metformin).
Investigational
Matched Description: … Janagliflozin is under investigation in clinical trial NCT03851432 (Janagliflozin Treat Type 2 Diabetes …
DNL343
DNL343 is under investigation in clinical trial NCT05842941 (HEALEY ALS Platform Trial - Regimen G DNL343).
Investigational
Matched Description: … DNL343 is under investigation in clinical trial NCT05842941 (HEALEY ALS Platform Trial - Regimen G DNL343 …
IQP-0528
IQP-0528 is under investigation in clinical trial NCT03082690 (ImQuest (IQP) DuoGel Phase 1 Pharmacokinetic Study).
Investigational
Matched Iupac: … 1-(cyclopropylmethyl)-6-(3,5-dimethylbenzoyl)-5-(propan-2-yl)-1,2,3,4-tetrahydropyrimidine-2,4-dione …
Matched Description: … IQP-0528 is under investigation in clinical trial NCT03082690 (ImQuest (IQP) DuoGel Phase 1 Pharmacokinetic …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Matched Description: … IQP-0528 is under investigation in clinical trial NCT03082690 (ImQuest (IQP) DuoGel Phase 1 Pharmacokinetic …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Ispinesib
Investigational
Matched Iupac: … N-(3-aminopropyl)-N-[(1R)-1-(3-benzyl-7-chloro-4-oxo-3,4-dihydroquinazolin-2-yl)-2-methylpropyl]-4-methylbenzamide …
Rilvegostomig
Rilvegostomig is under investigation in clinical trial NCT06109779 (Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (Artemide-biliary01)).
Investigational
Matched Description: … Rilvegostomig is under investigation in clinical trial NCT06109779 (Rilvegostomig + Chemotherapy as Adjuvant …
Ulocuplumab
Ulocuplumab is under investigation in Solid Tumor.
Investigational
Matched Description: … Ulocuplumab is under investigation in Solid Tumor. …
Piribedil
Piribedil has been investigated in Parkinson's Disease.
Investigational
Matched Iupac: … 2-{4-[(2H-1,3-benzodioxol-5-yl)methyl]piperazin-1-yl}pyrimidine …
Matched Description: … Piribedil has been investigated in Parkinson's Disease. …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Matched Description: … Piribedil has been investigated in Parkinson's Disease. …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Ligandrol
Ligandrol is an investigational selective androgen receptor modulator (SARM) for treatment of conditions such as muscle wasting and osteoporosis.
Investigational
Matched Iupac: … 4-[(2R)-2-[(1R)-2,2,2-trifluoro-1-hydroxyethyl]pyrrolidin-1-yl]-2-(trifluoromethyl)benzonitrile …
Matched Description: … Ligandrol is an investigational selective androgen receptor modulator (SARM) for treatment of conditions …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Matched Description: … Ligandrol is an investigational selective androgen receptor modulator (SARM) for treatment of conditions …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
S64315
S64315 (MIK665) is an inhibitor of induced myeloid leukemia cell differentiation protein Myeloid cell leukemia 1 (Mcl-1).
Investigational
Matched Description: … leukemia 1 (Mcl-1). ... S64315 (MIK665) is an inhibitor of induced myeloid leukemia cell differentiation protein Myeloid cell …
EXOB-001
EXOB-001 consists of extracellular vesicles derived from cultured human umbilical cord mesenchymal stromal cells.
Investigational
Matched Description: … EXOB-001 consists of extracellular vesicles derived from cultured human umbilical cord mesenchymal stromal …
Glepaglutide
Glepaglutide is under investigation in clinical trial NCT00868660 (Healthy Normal Single Ascending Dose and Crohn's Patient Multiple Ascending Dose).
Investigational
Matched Description: … Glepaglutide is under investigation in clinical trial NCT00868660 (Healthy Normal Single Ascending Dose …
CP-609754
LNK 754 has been investigated in Mild Alzheimer's Disease.
Investigational
Matched Iupac: … 6-[(R)-(4-chlorophenyl)(hydroxy)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-ethynylphenyl)-1-methyl-1,2-dihydroquinolin …
Matched Description: … LNK 754 has been investigated in Mild Alzheimer's Disease. …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Matched Description: … LNK 754 has been investigated in Mild Alzheimer's Disease. …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
RO-5028442
RO5028442 has been used in trials studying Autistic Disorder.
Investigational
Matched Iupac: … {2-[6-chloro-3-({3H-spiro[2-benzofuran-1,4'-piperidine]-1'-yl}carbonyl)-1H-indol-1-yl]ethyl}dimethylamine …
Matched Description: … RO5028442 has been used in trials studying Autistic Disorder. …
Matched Description: … RO5028442 has been used in trials studying Autistic Disorder. …
PM-060184
PM060184 has been used in trials studying Solid Tumors.
Investigational
Matched Iupac: … (1Z,4S,6Z)-1-[(2S)-2-[(2Z,4Z,6E,8S)-8-[(2S)-5-methoxy-6-oxo-3,6-dihydro-2H-pyran-2-yl]-6-methylnona-2,4,6 …
Matched Description: … PM060184 has been used in trials studying Solid Tumors. …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Matched Description: … PM060184 has been used in trials studying Solid Tumors. …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
BTRX-246040
BTRX-246040 is under investigation in clinical trial NCT03193398 (BTRX-246040 Administered Once Daily to Patients With Major Depressive Disorder).
Investigational
Matched Iupac: … 3-methyl-1H-pyrazol-1-yl]pyridin-3-yl}methanol ... {2-[4-({2'-chloro-4',4'-difluoro-4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran]-1-yl}methyl)- …
Matched Description: … BTRX-246040 is under investigation in clinical trial NCT03193398 (BTRX-246040 Administered Once Daily …
Matched Description: … BTRX-246040 is under investigation in clinical trial NCT03193398 (BTRX-246040 Administered Once Daily …
TNP-2092
TNP-2092 is under investigation in clinical trial NCT03964493 (TNP-2092 to Treat Acute Bacterial Skin and Skin Structure Infection).
Investigational
Matched Iupac: … 8-[(3R)-3-[1-({1-[(E)-{[(7S,9E,11S,12S,13S,14S,15R,16R,17S,18S,19E)-13-(acetyloxy)-2,15,17,27,29-pentahydroxy ... yl]-1-cyclopropyl-7-fluoro-9-methyl-4-oxo-4H-quinolizine-3-carboxylic acid ... 3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1^{4,7}.0^{5,28}]triaconta-1( ... 2,4,9,19,21,25(29),26-octaen-26-yl]methylidene}amino]piperidin-4-yl}(methyl)amino)cyclopropyl]pyrrolidin-1- …
Matched Description: … TNP-2092 is under investigation in clinical trial NCT03964493 (TNP-2092 to Treat Acute Bacterial Skin …
Matched Description: … TNP-2092 is under investigation in clinical trial NCT03964493 (TNP-2092 to Treat Acute Bacterial Skin …
Cobalt Co-60
Cobalt Co-60 is under investigation in clinical trial NCT02891083 (Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer).
Investigational
Matched Description: … Cobalt Co-60 is under investigation in clinical trial NCT02891083 (Adjuvant Therapies or Surgery Alone …
PRX-OTC
PRX-OTC is an intracellular enzyme replacement therapy designed to replace missing or defective enzyme in patients with ornithine transcarbamylase deficiency.
Investigational
Matched Description: … PRX-OTC is an intracellular enzyme replacement therapy designed to replace missing or defective enzyme in …
Tropatepine
Tropatepine has been used in France for its antiparkinsons activities .
Experimental
Matched Iupac: … (1R,5S)-8-methyl-3-{9-thiatricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3(8),4,6,11,13-hexaen-2-ylidene}-8-azabicyclo …
Matched Description: … Tropatepine has been used in France for its antiparkinsons activities [A175024]. …
Matched Description: … Tropatepine has been used in France for its antiparkinsons activities [A175024]. …
Displaying drugs 14776 - 14800 of 14815 in total